Statins and outcomes in patients with pneumonia: Not only healthy user bias

BMJ

Volumn 333, Issue 7578, 2006, Pages 1123-1124

  Mortensen, Eric M ^a   Restrepo, Marcos I ^a   Copeland, Laurel A ^a   Pugh, Mary jo V ^a   Anzueto, Antonio ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOFLOXACIN;

HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; ISCHEMIC HEART DISEASE; LETTER; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS;

BIAS (EPIDEMIOLOGY); COMMUNITY-ACQUIRED INFECTIONS; HEALTHY WORKER EFFECT; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ODDS RATIO; PNEUMONIA, BACTERIAL;

EID: 33845259590     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39038.509167.1F     Document Type: Letter

References (4)

1. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333: 999-1001. (11 November.)
2. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN,, et al Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162(9):1059-64.
3. Mortensen EM, Restrepo M, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Resp Res 2005; 6: 82.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE,, et al A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.